Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tranexamic acid versus saline in transforaminal lumbar interbody fusion surgery
ChiCTR1900024148Phase 4Completed
- Sponsor
- First Affiliated Hospital of Chongqing Medical University
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of tranexamic acid in lumbar intervertebral disc degenerative disease (LDDD) (2 arms), sponsored by First Affiliated Hospital of Chongqing Medical University. Primary endpoint: intraoperative blood loss. Started Jul 2018; status: completed.
02
Drugs
tranexamic acid
03
Conditions
lumbar intervertebral disc degenerative disease (LDDD)
Beyond the preview
Go deeper on ChiCTR1900024148.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900024148.